BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hebbel RP. Reconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine. Am J Hematol 2011;86:123-54. [PMID: 21264896 DOI: 10.1002/ajh.21952] [Cited by in Crossref: 110] [Cited by in F6Publishing: 99] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Mburu J, Odame I. Sickle cell disease: Reducing the global disease burden. Int J Lab Hematol 2019;41 Suppl 1:82-8. [PMID: 31069977 DOI: 10.1111/ijlh.13023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
2 Milton JN, Rooks H, Drasar E, McCabe EL, Baldwin CT, Melista E, Gordeuk VR, Nouraie M, Kato GR, Minniti C, Taylor J, Campbell A, Luchtman-Jones L, Rana S, Castro O, Zhang Y, Thein SL, Sebastiani P, Gladwin MT, Steinberg MH; Walk-PHAAST Investigators. Genetic determinants of haemolysis in sickle cell anaemia. Br J Haematol 2013;161:270-8. [PMID: 23406172 DOI: 10.1111/bjh.12245] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
3 Nathan DG. Guilt by association. Blood 2011;118:3758-9. [PMID: 21980046 DOI: 10.1182/blood-2011-08-370338] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
4 Shilo NR, Alawadi A, Allard-Coutu A, Robitaille N, Pastore Y, Bérubé D, Jacob SV, Abish S, Dauletbaev N, Lands LC. Airway hyperreactivity is frequent in non-asthmatic children with sickle cell disease. Pediatr Pulmonol 2016;51:950-7. [PMID: 26716600 DOI: 10.1002/ppul.23374] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
5 Sparkenbaugh EM, Chantrathammachart P, Mickelson J, van Ryn J, Hebbel RP, Monroe DM, Mackman N, Key NS, Pawlinski R. Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease. Blood 2014;123:1747-56. [PMID: 24449213 DOI: 10.1182/blood-2013-08-523936] [Cited by in Crossref: 75] [Cited by in F6Publishing: 69] [Article Influence: 9.4] [Reference Citation Analysis]
6 Rees DC, Robinson S, Howard J. How I manage red cell transfusions in patients with sickle cell disease. Br J Haematol 2018;180:607-17. [DOI: 10.1111/bjh.15115] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
7 Belcher JD, Nath KA, Vercellotti GM. Vasculotoxic and Proinflammatory Effects of Plasma Heme: Cell Signaling and Cytoprotective Responses. ISRN Oxidative Med 2013;2013:831596. [PMID: 25506596 DOI: 10.1155/2013/831596] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
8 Navarro SD, Beatriz A, Meza A, Pesarini JR, Gomes RDS, Karaziack CB, Cunha-laura AL, Monreal ACD, Romão W, Lacerda Júnior V, Mauro MDO, Oliveira RJ. A new synthetic resorcinolic lipid 3-Heptyl-3,4,6-trimethoxy-3H-isobenzofuran-1-one: Evaluation of toxicology and ability to potentiate the mutagenic and apoptotic effects of cyclophosphamide. European Journal of Medicinal Chemistry 2014;75:132-42. [DOI: 10.1016/j.ejmech.2014.01.057] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
9 Peter ID, Asani MO, Abdullahi SU, Aliyu I, Obaro SK, Bode-Thomas F. Pulmonary hypertension and right ventricular function in Nigerian children with sickle cell anaemia. Trans R Soc Trop Med Hyg 2019;113:489-96. [PMID: 31086994 DOI: 10.1093/trstmh/trz038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Buehler PW, Humar R, Schaer DJ. Haptoglobin Therapeutics and Compartmentalization of Cell-Free Hemoglobin Toxicity. Trends Mol Med 2020;26:683-97. [PMID: 32589936 DOI: 10.1016/j.molmed.2020.02.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
11 Morris CR. Alterations of the arginine metabolome in sickle cell disease: a growing rationale for arginine therapy. Hematol Oncol Clin North Am 2014;28:301-21. [PMID: 24589268 DOI: 10.1016/j.hoc.2013.11.008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
12 Ben Khaled M, Ouederni M, Mankai Y, Rekaya S, Ben Fraj I, Dhouib N, Kouki R, Mellouli F, Bejaoui M. Prevalence and predictive factors of splenic sequestration crisis among 423 pediatric patients with sickle cell disease in Tunisia. Blood Cells Mol Dis 2020;80:102374. [PMID: 31670184 DOI: 10.1016/j.bcmd.2019.102374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Salinas Cisneros G, Thein SL. Recent Advances in the Treatment of Sickle Cell Disease. Front Physiol 2020;11:435. [PMID: 32508672 DOI: 10.3389/fphys.2020.00435] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 10.5] [Reference Citation Analysis]
14 Bakeer N, James J, Roy S, Wansapura J, Shanmukhappa SK, Lorenz JN, Osinska H, Backer K, Huby AC, Shrestha A, Niss O, Fleck R, Quinn CT, Taylor MD, Purevjav E, Aronow BJ, Towbin JA, Malik P. Sickle cell anemia mice develop a unique cardiomyopathy with restrictive physiology. Proc Natl Acad Sci U S A 2016;113:E5182-91. [PMID: 27503873 DOI: 10.1073/pnas.1600311113] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 7.3] [Reference Citation Analysis]
15 Strader MB, Liang H, Meng F, Harper J, Ostrowski DA, Henry ER, Shet AS, Eaton WA, Thein SL, Alayash AI. Interactions of an Anti-Sickling Drug with Hemoglobin in Red Blood Cells from a Patient with Sickle Cell Anemia. Bioconjug Chem 2019;30:568-71. [PMID: 30794381 DOI: 10.1021/acs.bioconjchem.9b00130] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
16 Charrin E, Dubé JJ, Connes P, Pialoux V, Ghosh S, Faes C, Ofori-acquah SF, Martin C. Moderate exercise training decreases inflammation in transgenic sickle cell mice. Blood Cells, Molecules, and Diseases 2018;69:45-52. [DOI: 10.1016/j.bcmd.2017.06.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
17 Stauffer E, Poutrel S, Cannas G, Gauthier A, Fort R, Bertrand Y, Renoux C, Joly P, Boisson C, Hot A, Peter-Derex L, Pialoux V, PetitJean T, Connes P. Nocturnal Hypoxemia Rather Than Obstructive Sleep Apnea Is Associated With Decreased Red Blood Cell Deformability and Enhanced Hemolysis in Patients With Sickle Cell Disease. Front Physiol 2021;12:743399. [PMID: 34630163 DOI: 10.3389/fphys.2021.743399] [Reference Citation Analysis]
18 Lionnet F, Hammoudi N, Stojanovic KS, Avellino V, Grateau G, Girot R, Haymann JP. Hemoglobin sickle cell disease complications: a clinical study of 179 cases. Haematologica 2012;97:1136-41. [PMID: 22315500 DOI: 10.3324/haematol.2011.055202] [Cited by in Crossref: 78] [Cited by in F6Publishing: 67] [Article Influence: 7.8] [Reference Citation Analysis]
19 Vercellotti GM, Khan FB, Nguyen J, Chen C, Bruzzone CM, Bechtel H, Brown G, Nath KA, Steer CJ, Hebbel RP, Belcher JD. H-ferritin ferroxidase induces cytoprotective pathways and inhibits microvascular stasis in transgenic sickle mice. Front Pharmacol 2014;5:79. [PMID: 24860503 DOI: 10.3389/fphar.2014.00079] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
20 Conran N, Belcher JD. Inflammation in sickle cell disease. Clin Hemorheol Microcirc 2018;68:263-99. [PMID: 29614637 DOI: 10.3233/CH-189012] [Cited by in Crossref: 58] [Cited by in F6Publishing: 34] [Article Influence: 14.5] [Reference Citation Analysis]
21 Gomperts E, Belcher JD, Otterbein LE, Coates TD, Wood J, Skolnick BE, Levy H, Vercellotti GM. The role of carbon monoxide and heme oxygenase in the prevention of sickle cell disease vaso-occlusive crises. Am J Hematol 2017;92:569-82. [PMID: 28378932 DOI: 10.1002/ajh.24750] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
22 Ballas SK, Kesen MR, Goldberg MF, Lutty GA, Dampier C, Osunkwo I, Wang WC, Hoppe C, Hagar W, Darbari DS, Malik P. Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. ScientificWorldJournal 2012;2012:949535. [PMID: 22924029 DOI: 10.1100/2012/949535] [Cited by in Crossref: 82] [Cited by in F6Publishing: 74] [Article Influence: 8.2] [Reference Citation Analysis]
23 Cita KC, Ferdinand S, Connes P, Brudey L, Tressières B, Etienne-Julan M, Lemonne N, Tarer V, Elion J, Romana M. Association of adenylyl cyclase 6 rs3730070 polymorphism and hemolytic level in patients with sickle cell anemia. Blood Cells Mol Dis 2016;58:21-5. [PMID: 27067484 DOI: 10.1016/j.bcmd.2016.02.006] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
24 Shabani E, Vercellotti GM, John CC. Reply to Eisenhut. Clin Infect Dis 2015;60:1138-9. [PMID: 25527649 DOI: 10.1093/cid/ciu1151] [Reference Citation Analysis]
25 Okumura JV, Silva DG, Torres LS, Belini-Junior E, Barberino WM, Oliveira RG, Carrocini GC, Gelaleti GB, Lobo CL, Bonini-Domingos CR. Inheritance of the Bantu/Benin haplotype causes less severe hemolytic and oxidative stress in sickle cell anemia patients treated with hydroxycarbamide. J Hum Genet 2016;61:605-11. [PMID: 26961071 DOI: 10.1038/jhg.2016.16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
26 Agha H, El Tagui M, El Ghamrawy M, Hady MA. The 6-min walk test: an independent correlate of elevated tricuspid regurgitant jet velocity in children and young adult sickle cell patients. Ann Hematol. [DOI: 10.1007/s00277-014-2030-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
27 Radhakrishnan DK, Bendiak GN, Mateos-Corral D, Al-Saleh S, Bhattacharjee R, Kirby-Allen M, Grasemann H. Lower airway nitric oxide is increased in children with sickle cell disease. J Pediatr 2012;160:93-7. [PMID: 21868036 DOI: 10.1016/j.jpeds.2011.06.048] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
28 Greenwood S, Deane C, Rees OL, Freedman B, Kumar S, Ben Ramadan N, Wilkinson S, Marais G, Lord J, Chakravorty S, Height SE, Gardner K, Rees DC. The significance of inadequate transcranial Doppler studies in children with sickle cell disease. PLoS One 2017;12:e0181681. [PMID: 28742875 DOI: 10.1371/journal.pone.0181681] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
29 Kassim AA, Payne AB, Rodeghier M, Macklin EA, Strunk RC, DeBaun MR. Low forced expiratory volume is associated with earlier death in sickle cell anemia. Blood 2015;126:1544-50. [PMID: 26261241 DOI: 10.1182/blood-2015-05-644435] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
30 Buehler PW, Baek JH, Lisk C, Connor I, Sullivan T, Kominsky D, Majka S, Stenmark KR, Nozik-Grayck E, Bonaventura J. Free hemoglobin induction of pulmonary vascular disease: evidence for an inflammatory mechanism. Am J Physiol Lung Cell Mol Physiol. 2012;303:L312-L326. [PMID: 22728465 DOI: 10.1152/ajplung.00074.2012] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
31 Camus SM, De Moraes JA, Bonnin P, Abbyad P, Le Jeune S, Lionnet F, Loufrani L, Grimaud L, Lambry JC, Charue D, Kiger L, Renard JM, Larroque C, Le Clésiau H, Tedgui A, Bruneval P, Barja-Fidalgo C, Alexandrou A, Tharaux PL, Boulanger CM, Blanc-Brude OP. Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease. Blood 2015;125:3805-14. [PMID: 25827830 DOI: 10.1182/blood-2014-07-589283] [Cited by in Crossref: 158] [Cited by in F6Publishing: 155] [Article Influence: 22.6] [Reference Citation Analysis]
32 van der Land V, Peters M, Biemond BJ, Heijboer H, Harteveld CL, Fijnvandraat K. Markers of endothelial dysfunction differ between subphenotypes in children with sickle cell disease. Thrombosis Research 2013;132:712-7. [DOI: 10.1016/j.thromres.2013.10.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
33 Morris CR, Kim HY, Trachtenberg F, Wood J, Quinn CT, Sweeters N, Kwiatkowski JL, Thompson AA, Giardina PJ, Boudreaux J, Olivieri NF, Porter JB, Neufeld EJ, Vichinsky EP; Thalassemia Clinical Research Network. Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report. Blood 2011;118:3794-802. [PMID: 21772051 DOI: 10.1182/blood-2010-11-319152] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.0] [Reference Citation Analysis]
34 Kucukal E, Ilich A, Key NS, Little JA, Gurkan UA. Red Blood Cell Adhesion to Heme-Activated Endothelial Cells Reflects Clinical Phenotype in Sickle Cell Disease. Am J Hematol 2018. [PMID: 29905377 DOI: 10.1002/ajh.25159] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
35 Than NN, Soe HHK, Palaniappan SK, Abas AB, De Franceschi L. Magnesium for treating sickle cell disease. Cochrane Database Syst Rev 2019;9:CD011358. [PMID: 31498421 DOI: 10.1002/14651858.CD011358.pub3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Ware RE, de Montalembert M, Tshilolo L, Abboud MR. Sickle cell disease. The Lancet 2017;390:311-23. [DOI: 10.1016/s0140-6736(17)30193-9] [Cited by in Crossref: 332] [Cited by in F6Publishing: 138] [Article Influence: 66.4] [Reference Citation Analysis]
37 Noubouossie DCF, Lê PQ, Rozen L, Ziereisen F, Willems D, Demulder A, Ferster A. Thrombin generation in children with sickle cell disease: relationship with age, hemolysis, transcranial doppler velocity, and hydroxyurea treatment. Eur J Haematol 2013;91:46-54. [DOI: 10.1111/ejh.12113] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
38 Charrin E, Aufradet E, Douillard A, Romdhani A, Souza GD, Bessaad A, Faes C, Chirico EN, Pialoux V, Martin C. Oxidative stress is decreased in physically active sickle cell SAD mice. Br J Haematol 2015;168:747-56. [DOI: 10.1111/bjh.13207] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
39 Shenoy S. Hematopoietic stem-cell transplantation for sickle cell disease: current evidence and opinions. Ther Adv Hematol 2013;4:335-44. [PMID: 24082994 DOI: 10.1177/2040620713483063] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
40 Alabi OJ, Adegboyega FN, Olawoyin DS, Babatunde OA. Functional foods: promising therapeutics for Nigerian Children with sickle cell diseases. Heliyon 2022;8:e09630. [DOI: 10.1016/j.heliyon.2022.e09630] [Reference Citation Analysis]
41 Damanhouri GA, Jarullah J, Marouf S, Hindawi SI, Mushtaq G, Kamal MA. Clinical biomarkers in sickle cell disease. Saudi J Biol Sci 2015;22:24-31. [PMID: 25561879 DOI: 10.1016/j.sjbs.2014.09.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
42 Fox BD, Okumiya T, Attas-Fox L, Kassirer M, Raviv Y, Kramer MR. Raised erythrocyte creatine in patients with pulmonary arterial hypertension--evidence for subclinical hemolysis. Respir Med 2012;106:594-8. [PMID: 22244549 DOI: 10.1016/j.rmed.2011.12.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
43 Gladwin MT. Prevalence, risk factors and mortality of pulmonary hypertension defined by right heart catheterization in patients with sickle cell disease. Expert Rev Hematol 2011;4:593-6. [PMID: 22077523 DOI: 10.1586/ehm.11.66] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
44 Conran N, Torres L. cGMP modulation therapeutics for sickle cell disease. Exp Biol Med (Maywood) 2019;244:132-46. [PMID: 30691292 DOI: 10.1177/1535370219827276] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
45 Rao DR, Phipatanakul W. An Overview of Fractional Exhaled Nitric Oxide and Children with Asthma. Expert Rev Clin Immunol 2016;12:521-30. [PMID: 26757849 DOI: 10.1586/1744666X.2016.1141049] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
46 Castilhos LG, Adefegha SA, Doleski PH, Bertoldo TM, Moritz CEJ, Casali EA, Leal DB. NTPDase, 5'-nucleotidase and adenosine deaminase activities and purine levels in serum of sickle cell anemia patients. J Appl Biomed 2018;16:208-13. [DOI: 10.1016/j.jab.2017.12.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
47 Hebbel RP. Ischemia-reperfusion injury in sickle cell anemia: relationship to acute chest syndrome, endothelial dysfunction, arterial vasculopathy, and inflammatory pain. Hematol Oncol Clin North Am 2014;28:181-98. [PMID: 24589261 DOI: 10.1016/j.hoc.2013.11.005] [Cited by in Crossref: 86] [Cited by in F6Publishing: 78] [Article Influence: 10.8] [Reference Citation Analysis]
48 Ghosh S, Adisa OA, Chappa P, Tan F, Jackson KA, Archer DR, Ofori-Acquah SF. Extracellular hemin crisis triggers acute chest syndrome in sickle mice. J Clin Invest 2013;123:4809-20. [PMID: 24084741 DOI: 10.1172/JCI64578] [Cited by in Crossref: 168] [Cited by in F6Publishing: 119] [Article Influence: 21.0] [Reference Citation Analysis]
49 Kato GJ, Steinberg MH, Gladwin MT. Intravascular hemolysis and the pathophysiology of sickle cell disease. J Clin Invest 2017;127:750-60. [PMID: 28248201 DOI: 10.1172/JCI89741] [Cited by in Crossref: 245] [Cited by in F6Publishing: 142] [Article Influence: 49.0] [Reference Citation Analysis]
50 Colombatti R, Varotto E, Ricato S, Nardo D, Maschietto N, Teso S, Pillon M, Messina C, Milanesi O, Sainati L. Tricuspid regurgitant velocity elevation in a three-year old child with sickle cell anemia and recurrent acute chest syndromes reversed not by hydroxyurea but by bone marrow transplantation. Hematol Rep 2011;3:e12. [PMID: 22184533 DOI: 10.4081/hr.2011.e12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
51 Balayssac-Siransy E, Connes P, Tuo N, Danho C, Diaw M, Sanogo I, Hardy-Dessources MD, Samb A, Ballas SK, Bogui P. Mild haemorheological changes induced by a moderate endurance exercise in patients with sickle cell anaemia. Br J Haematol 2011;154:398-407. [PMID: 21569006 DOI: 10.1111/j.1365-2141.2011.08728.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
52 Wang D, Piknova B, Solomon SB, Cortes-Puch I, Kern SJ, Sun J, Kanias T, Gladwin MT, Helms C, Kim-Shapiro DB, Schechter AN, Natanson C. In vivo reduction of cell-free methemoglobin to oxyhemoglobin results in vasoconstriction in canines. Transfusion 2013;53:3149-63. [PMID: 23488474 DOI: 10.1111/trf.12162] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
53 Cox SE, Soka D, Kirkham FJ, Newton CR, Prentice AM, Makani J, Younoszai AK. Tricuspid regurgitant jet velocity and hospitalization in Tanzanian children with sickle cell anemia. Haematologica 2014;99:e1-4. [PMID: 24425690 DOI: 10.3324/haematol.2013.089235] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
54 Kassa T, Strader MB, Nakagawa A, Zapol WM, Alayash AI. Targeting βCys93 in hemoglobin S with an antisickling agent possessing dual allosteric and antioxidant effects. Metallomics 2017;9:1260-70. [PMID: 28770911 DOI: 10.1039/c7mt00104e] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
55 Kassa T, Jana S, Strader MB, Meng F, Jia Y, Wilson MT, Alayash AI. Sickle Cell Hemoglobin in the Ferryl State Promotes βCys-93 Oxidation and Mitochondrial Dysfunction in Epithelial Lung Cells (E10). J Biol Chem 2015;290:27939-58. [PMID: 26396189 DOI: 10.1074/jbc.M115.651257] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
56 Banerjee S, Jia Y, Siburt CJ, Abraham B, Wood F, Bonaventura C, Henkens R, Crumbliss AL, Alayash AI. Haptoglobin alters oxygenation and oxidation of hemoglobin and decreases propagation of peroxide-induced oxidative reactions. Free Radic Biol Med 2012;53:1317-26. [PMID: 22841869 DOI: 10.1016/j.freeradbiomed.2012.07.023] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
57 Gomez E, Morris CR. Asthma management in sickle cell disease. Biomed Res Int 2013;2013:604140. [PMID: 24324967 DOI: 10.1155/2013/604140] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
58 Bonaventura C, Henkens R, Alayash AI, Banerjee S, Crumbliss AL. Molecular controls of the oxygenation and redox reactions of hemoglobin. Antioxid Redox Signal 2013;18:2298-313. [PMID: 23198874 DOI: 10.1089/ars.2012.4947] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
59 Hebbel RP, Hedlund BE. Sickle hemoglobin oxygen affinity-shifting strategies have unequal cerebrovascular risks. Am J Hematol 2018;93:321-5. [PMID: 29150874 DOI: 10.1002/ajh.24975] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
60 Dubert M, Elion J, Tolo A, Diallo DA, Diop S, Diagne I, Sanogo I, Belinga S, Guifo O, Wamba G, Ngo Sack F, Boidy K, Kamara I, Traore Y, Diakite CO, Gbonon V, Faye BF, Seck M, Deme Ly I, Chelo D, N'Guetta R, Diop IB, Gaye B, Jouven X, Ranque B. Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease in Africa. Blood 2017;130:2215-23. [PMID: 28931524 DOI: 10.1182/blood-2016-12-755777] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
61 Mehari A, Alam S, Tian X, Cuttica MJ, Barnett CF, Miles G, Xu D, Seamon C, Adams-Graves P, Castro OL, Minniti CP, Sachdev V, Taylor JG 6th, Kato GJ, Machado RF. Hemodynamic predictors of mortality in adults with sickle cell disease. Am J Respir Crit Care Med 2013;187:840-7. [PMID: 23348978 DOI: 10.1164/rccm.201207-1222OC] [Cited by in Crossref: 78] [Cited by in F6Publishing: 41] [Article Influence: 8.7] [Reference Citation Analysis]
62 Machado RF, Farber HW. Pulmonary hypertension associated with chronic hemolytic anemia and other blood disorders. Clin Chest Med. 2013;34:739-752. [PMID: 24267302 DOI: 10.1016/j.ccm.2013.08.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
63 Irwin DC, Baek JH, Hassell K, Nuss R, Eigenberger P, Lisk C, Loomis Z, Maltzahn J, Stenmark KR, Nozik-Grayck E. Hemoglobin-induced lung vascular oxidation, inflammation, and remodeling contribute to the progression of hypoxic pulmonary hypertension and is attenuated in rats with repeated-dose haptoglobin administration. Free Radic Biol Med. 2015;82:50-62. [PMID: 25656991 DOI: 10.1016/j.freeradbiomed.2015.01.012] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 5.3] [Reference Citation Analysis]
64 Setty BN, Key NS, Rao AK, Gayen-Betal S, Krishnan S, Dampier CD, Stuart MJ. Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis. Br J Haematol 2012;157:370-80. [PMID: 22360627 DOI: 10.1111/j.1365-2141.2012.09065.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
65 Kupesiz A, Celmeli G, Dogan S, Antmen B, Aslan M. The effect of hemolysis on plasma oxidation and nitration in patients with sickle cell disease. Free Radic Res 2012;46:883-90. [PMID: 22509726 DOI: 10.3109/10715762.2012.686037] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
66 Sundararajan S, Gaston B. Sickle cell disease does not decrease pulmonary nitric oxide. J Pediatr 2012;160:6-7. [PMID: 21924434 DOI: 10.1016/j.jpeds.2011.08.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
67 Hebbel RP, Belcher JD, Vercellotti GM. The multifaceted role of ischemia/reperfusion in sickle cell anemia. J Clin Invest 2020;130:1062-72. [PMID: 32118586 DOI: 10.1172/JCI133639] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
68 Alayash AI. Hemoglobin-Based Blood Substitutes and the Treatment of Sickle Cell Disease: More Harm than Help? Biomolecules 2017;7:E2. [PMID: 28054978 DOI: 10.3390/biom7010002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
69 Dybas J, Alcicek FC, Wajda A, Kaczmarska M, Zimna A, Bulat K, Blat A, Stepanenko T, Mohaissen T, Szczesny-malysiak E, Perez-guaita D, Wood BR, Marzec KM. Trends in biomedical analysis of red blood cells – Raman spectroscopy against other spectroscopic, microscopic and classical techniques. TrAC Trends in Analytical Chemistry 2022;146:116481. [DOI: 10.1016/j.trac.2021.116481] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
70 Piel FB, Williams TN. Subphenotypes of sickle cell disease in Africa. Blood 2017;130:2157-8. [PMID: 29146819 DOI: 10.1182/blood-2017-10-808550] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Telen MJ, Malik P, Vercellotti GM. Therapeutic strategies for sickle cell disease: towards a multi-agent approach. Nat Rev Drug Discov 2019;18:139-58. [PMID: 30514970 DOI: 10.1038/s41573-018-0003-2] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 19.7] [Reference Citation Analysis]
72 Rodeghiero F, Ruggeri M. Short- and long-term risks of splenectomy for benign haematological disorders: should we revisit the indications? Br J Haematol 2012;158:16-29. [PMID: 22571181 DOI: 10.1111/j.1365-2141.2012.09146.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 48] [Article Influence: 6.9] [Reference Citation Analysis]
73 Grau M, Nader E, Jerke M, Schenk A, Renoux C, Dietz T, Collins B, Bizjak DA, Joly P, Bloch W, Prokop A, Connes P. Impact of A Six Week Training Program on Ventilatory Efficiency, Red Blood Cell Rheological Parameters and Red Blood Cell Nitric Oxide Signaling in Young Sickle Cell Anemia Patients: A Pilot Study. J Clin Med 2019;8:E2155. [PMID: 31817545 DOI: 10.3390/jcm8122155] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
74 Stotesbury H, Hales PW, Hood AM, Koelbel M, Kawadler JM, Saunders DE, Sahota S, Rees DC, Wilkey O, Layton M, Pelidis M, Inusa BPD, Howard J, Chakravorty S, Clark CA, Kirkham FJ. Individual Watershed Areas in Sickle Cell Anemia: An Arterial Spin Labeling Study. Front Physiol 2022;13:865391. [DOI: 10.3389/fphys.2022.865391] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Schaer DJ, Buehler PW, Alayash AI, Belcher JD, Vercellotti GM. Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Blood 2013;121:1276-84. [PMID: 23264591 DOI: 10.1182/blood-2012-11-451229] [Cited by in F6Publishing: 375] [Reference Citation Analysis]
76 Brousse V, Makani J, Rees DC. Management of sickle cell disease in the community. BMJ 2014;348:g1765. [PMID: 24613806 DOI: 10.1136/bmj.g1765] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
77 Runge A, Brazel D, Pakbaz Z. A case of Sβ+ sickle cell disease diagnosed in adulthood following acute stroke: it's 2021, are we there yet? J Community Hosp Intern Med Perspect 2021;11:713-8. [PMID: 34567471 DOI: 10.1080/20009666.2021.1954285] [Reference Citation Analysis]
78 Hassell KL. Pulmonary hypertension, tricuspid regurgitant velocity screening, and the nitric oxide pathway. Hematology Am Soc Hematol Educ Program 2011;2011:419-26. [PMID: 22160068 DOI: 10.1182/asheducation-2011.1.419] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
79 Shenoy S. Hematopoietic stem cell transplantation for sickle cell disease: current practice and emerging trends. Hematology Am Soc Hematol Educ Program 2011;2011:273-9. [PMID: 22160045 DOI: 10.1182/asheducation-2011.1.273] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
80 Connes P, Lamarre Y, Waltz X, Ballas SK, Lemonne N, Etienne-Julan M, Hue O, Hardy-Dessources MD, Romana M. Haemolysis and abnormal haemorheology in sickle cell anaemia. Br J Haematol 2014;165:564-72. [PMID: 24611951 DOI: 10.1111/bjh.12786] [Cited by in Crossref: 71] [Cited by in F6Publishing: 74] [Article Influence: 8.9] [Reference Citation Analysis]
81 Joly P, Garnier N, Kebaili K, Renoux C, Dony A, Cheikh N, Renard C, Ceraulo A, Cuzzubbo D, Pondarré C, Martin C, Pialoux V, Francina A, Bertrand Y, Connes P. G6PD deficiency and absence of α-thalassemia increase the risk for cerebral vasculopathy in children with sickle cell anemia. Eur J Haematol 2016;96:404-8. [PMID: 26072930 DOI: 10.1111/ejh.12607] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
82 Waltz X, Romana M, Lalanne-Mistrih ML, Machado RF, Lamarre Y, Tarer V, Hardy-Dessources MD, Tressières B, Divialle-Doumdo L, Petras M, Maillard F, Etienne-Julan M, Connes P. Hematologic and hemorheological determinants of resting and exercise-induced hemoglobin oxygen desaturation in children with sickle cell disease. Haematologica 2013;98:1039-44. [PMID: 23539539 DOI: 10.3324/haematol.2013.083576] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
83 Lee N, Makani J, Tluway F, Makubi A, Armitage AE, Pasricha SR, Drakesmith H, Prentice AM, Cox SE. Decreased Hepcidin Levels Are Associated with Low Steady-state Hemoglobin in Children With Sickle Cell Disease in Tanzania. EBioMedicine 2018;34:158-64. [PMID: 30056060 DOI: 10.1016/j.ebiom.2018.07.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
84 Almeida LEF, Kamimura S, de Souza Batista CM, Spornick N, Nettleton MY, Walek E, Smith ML, Finkel JC, Darbari DS, Wakim P, Quezado ZMN. Sickle cell disease subjects and mouse models have elevated nitrite and cGMP levels in blood compartments. Nitric Oxide 2020;94:79-91. [PMID: 31689491 DOI: 10.1016/j.niox.2019.10.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
85 Detterich JA, Kato RM, Rabai M, Meiselman HJ, Coates TD, Wood JC. Chronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease. Blood 2015;126:703-10. [PMID: 26036801 DOI: 10.1182/blood-2014-12-614370] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 7.4] [Reference Citation Analysis]
86 Sachdev V, Kato GJ, Gibbs JS, Barst RJ, Machado RF, Nouraie M, Hassell KL, Little JA, Schraufnagel DE, Krishnamurti L, Novelli EM, Girgis RE, Morris CR, Rosenzweig EB, Badesch DB, Lanzkron S, Castro OL, Taylor JG 6th, Hannoush H, Goldsmith JC, Gladwin MT, Gordeuk VR; Walk-PHASST Investigators. Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom. Circulation 2011;124:1452-60. [PMID: 21900080 DOI: 10.1161/CIRCULATIONAHA.111.032920] [Cited by in Crossref: 88] [Cited by in F6Publishing: 59] [Article Influence: 8.0] [Reference Citation Analysis]
87 Gladwin MT, Sachdev V. Cardiovascular abnormalities in sickle cell disease. J Am Coll Cardiol 2012;59:1123-33. [PMID: 22440212 DOI: 10.1016/j.jacc.2011.10.900] [Cited by in Crossref: 135] [Cited by in F6Publishing: 132] [Article Influence: 13.5] [Reference Citation Analysis]
88 Njoku F, Zhang X, Shah BN, Machado RF, Han J, Saraf SL, Gordeuk VR. Biomarkers of clinical severity in treated and untreated sickle cell disease: a comparison by genotypes of a single center cohort and African Americans in the NHANES study. Br J Haematol 2021. [PMID: 34268729 DOI: 10.1111/bjh.17682] [Reference Citation Analysis]
89 Nouraie M, Lee JS, Zhang Y, Kanias T, Zhao X, Xiong Z, Oriss TB, Zeng Q, Kato GJ, Gibbs JS, Hildesheim ME, Sachdev V, Barst RJ, Machado RF, Hassell KL, Little JA, Schraufnagel DE, Krishnamurti L, Novelli E, Girgis RE, Morris CR, Rosenzweig EB, Badesch DB, Lanzkron S, Castro OL, Goldsmith JC, Gordeuk VR, Gladwin MT; Walk-PHASST Investigators and Patients. The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe. Haematologica 2013;98:464-72. [PMID: 22983573 DOI: 10.3324/haematol.2012.068965] [Cited by in Crossref: 115] [Cited by in F6Publishing: 118] [Article Influence: 11.5] [Reference Citation Analysis]
90 Renella R. Clinically-oriented proteomic investigation of sickle cell disease: Opportunities and challenges. Prot Clin Appl 2016;10:816-30. [DOI: 10.1002/prca.201500133] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
91 Rees DC, Gibson JS. Biomarkers in sickle cell disease: Review. British Journal of Haematology 2012;156:433-45. [DOI: 10.1111/j.1365-2141.2011.08961.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 6.1] [Reference Citation Analysis]
92 Wykes C, Rees DC. The safety and efficacy of hydroxycarbamide in infants with sickle cell anemia. Expert Rev Hematol 2011;4:407-9. [PMID: 21801131 DOI: 10.1586/ehm.11.40] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
93 Rees DC. To begin at the beginning: sickle cell disease in Africa. Lancet Haematol 2014;1:e50-1. [PMID: 27030152 DOI: 10.1016/S2352-3026(14)00006-4] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
94 Chirico EN, Pialoux V. Role of oxidative stress in the pathogenesis of sickle cell disease. IUBMB Life 2012;64:72-80. [DOI: 10.1002/iub.584] [Cited by in Crossref: 120] [Cited by in F6Publishing: 120] [Article Influence: 10.9] [Reference Citation Analysis]
95 Than NN, Soe HHK, Palaniappan SK, Abas AB, De Franceschi L. Magnesium for treating sickle cell disease. Cochrane Database Syst Rev 2017;4:CD011358. [PMID: 28409830 DOI: 10.1002/14651858.CD011358.pub2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
96 Quinn CT, Smith EP, Arbabi S, Khera PK, Lindsell CJ, Niss O, Joiner CH, Franco RS, Cohen RM. Biochemical surrogate markers of hemolysis do not correlate with directly measured erythrocyte survival in sickle cell anemia. Am J Hematol 2016;91:1195-201. [PMID: 27648808 DOI: 10.1002/ajh.24562] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
97 Carden MA, Fasano RM, Meier ER. Not all red cells sickle the same: Contributions of the reticulocyte to disease pathology in sickle cell anemia. Blood Rev 2020;40:100637. [PMID: 31735458 DOI: 10.1016/j.blre.2019.100637] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
98 Noomuna P, Risinger M, Zhou S, Seu K, Man Y, An R, Sheik DA, Wan J, Little JA, Gurkan UA, Turrini FM, Kalfa T, Low PS. Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease. Br J Haematol 2020;190:599-609. [PMID: 32346864 DOI: 10.1111/bjh.16671] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
99 Nebor D, Bowers A, Hardy-Dessources MD, Knight-Madden J, Romana M, Reid H, Barthélémy JC, Cumming V, Hue O, Elion J, Reid M, Connes P; CAREST Study Group. Frequency of pain crises in sickle cell anemia and its relationship with the sympatho-vagal balance, blood viscosity and inflammation. Haematologica 2011;96:1589-94. [PMID: 21750084 DOI: 10.3324/haematol.2011.047365] [Cited by in Crossref: 59] [Cited by in F6Publishing: 66] [Article Influence: 5.4] [Reference Citation Analysis]